CD33 and acute myeloid leukemia: Next, we compared the AML-related antigen (CD33, IL3RA, and CLEC12A) expression levels of normal EC populations from the heart and liver, normal BM-derived HSPC, and AML patient-derived progenitor-like cells (Supplementary Figure 9B).